ABSTRACT : Embryonic stem (ES) cells can self-renew and differentiate to various cells depending on the culture condition. Although ES cells are a good model for cell type specification and can be useful for application in clinics in the future, studies on ES cells have many experimental restraints including low transfection efficiency and transgene expression. Here, we observed that transgene expression after transfection was enhanced by treatment with histone deacetylse (HDAC) inhibitors such as trichostatin A, sodium butyrate, and valproic acid. Transfection was performed using conventional transfection reagents with a retroviral vector encoding GFP under the control of CMV promoter as a reporter. Treatment of ES cells with HDAC inhibitors after transfection increased population of GFP positive cells up to 180% compared with untreated control. ES cells showed normal expression of stem cell markers after treatment with HDAC inhibitors. Transgene expression was further enhanced by modifying transfection procedure. GFP positive cells selected after transfection were proved to have the stem cell properties. Our improved protocol for enhanced gene delivery and expression in mouse ES cells without hampering ES cell properties will be useful for study and application of ES cells.
INTRODUCTION
ES cells are pluripotent cells derived from the inner cell mass (ICM) of embryos (Evans & Kaufman, 1981; Thomson et al., 1998) . ES cells are able to self-renew in an unlimited and symmetrical manner and have the capability of differentiation to multiple cell lineages in vitro (Brook & Gardner, 1997; Nagy et al., 1990) . Potentials of ES cells have positioned ES cells as a good model system, therefore now ES cells are widely used for studying molecular mechanisms involved in self renewal/differentiation and development, cell therapy, and drug screening (Bain et al., 1995; Lerou and Daley, 2005; Sartipy et al., 2007) . To facilitate these studies, a rapid and effective gene transfer method is needed. Several techniques have been adopted to deliver genes into ES cells until now; electroporation (Mamo et al., 2010) , liposome-based transfection methods (Ko et al., 2009) , nucleofection (Lakshmipathy et al., 2004) , Manuscript received 23 November 2013, Received in revised form 7 December 2013, Accepted 13 December 2013viral transfection (Gropp et al., 2003; Ma et al., 2003) , and magnetofection (Lee et al., 2008) . However, generally the transfection efficiency is not high. Furthermore, there is a pitfall also in expression of foreign genes in ES cells. Major constraint is that integration into the genome is poor and the exogenous gene is often silenced even when it has been successfully integrated into the genome.
For example, in the case of transfection with retroviral vector, DNA methylation in the LTR leads to retrovirus silencing and defines the promoter region CpGs as a repressive element in ES cells (Swindle et al., 2004) . In addition, ES cells tend to differentiate during the selection procedure and obtaining a reasonably pure cell line is very difficult (Wiles & Johansson, 1999) .
To regulate expression of a specific gene, cells have to finely control the coiling and uncoiling of DNA around histones. Acetylation and deacetylation of histones contribute to the epigenetic regulation (Grunstein, 1997) . There are two classes of enzymes involved in determining the state of histone acetylation, histone acetyl transferases (HAT) and histone deacetylse (HDAC). HDAC inhibitors induced changes in the acetylation status of chromatin and other non-histone proteins, leading to changes in gene expression (Marks et al., 2000) .
Trials to improve the efficiency of gene transfer and gene expression using HDAC inhibitors have been performed in various cells. It was reported that HDAC inhibitors enhance the transcription of adenoviral transgenes in cancer cells (Dion et al., 1997; Goldsmith et al., 2003; Kitazono et al., 2001) . For example, a HDAC inhibitor FK228 has the capability to augment adenoviral transgene expression in several different cancer cell lines (Goldsmith et al., 2003) . Adenoviral transgene products were amplified by sodium butyrate (NaB: 0.5-5 mM) and trichostatin A (TSA: 0.1-1 μM) in HeLa and A549 cells (Dion et al., 1997) . According to a recent study, HDAC inhibitors such as TSA, valproic acid (VPA) and OSU-HDAC42 enhance the expression of genes under the control of a CMV promoter in vitro and in vivo (Lai et al., 2010) . with 5-Aza-dC (inhibitor of DNA methylase) induces synergistic activation of a transgene, it is likely that there is a cross-talk between histone acetylation and DNA methylation (Choi et al., 2005 ).
Here, we tested the effect of HDAC inhibitors on transfection in mouse ES cells and found that HDAC inhibitors enhance the transgene expression. In addition, we further enhanced gene delivery and transgene expression by modifying transfection condition. 
MATERIALS AND METHODS

Maintenance of mouse ES cells
Transfection of ES cells followed by treatment
with HDAC inhibitors R1 cells were cultured on 0.1% gelatin-coated plates in ES medium supplemented with leukemia inhibitory factor (LIF, 10 ng/ml). R1 cells were harvested using TrypLE solution and then 4×10 5 cells were seeded into 0.1% gelatin-coated 12 well plates 6 hr, 9 hr, 12 hr, and 16 hr prior to transfection. The pMSCV-neo-CMV-GFP (pMSCV-GFP) construct was generated in this study using pMSCV-neo as a parental vector (Grez et al., 1990; Miller and Rosman, 1989) . The pMSCV-GFP vector was isolated using Qiagen plasmid MIDI-prep kit (Qiagen, West Sussex, UK). 
RT-PCR
Total RNA was isolated using TRI reagent ® , according to the manufacturer's protocol (MRC, Cincinnati, OH, USA). The final pellet was dissolved in 20 μl of diethylpyrocarbonate (DEPC)-treated distilled water. 5 μg of total RNA was reverse-transcribed in the first-strand buffer containing 6 μg/ml oligo (dT) primer, 50 U M-MLV reverse GTTCTCTTTGGAAAGGTGTTG-3' (antisense) (313 bp); Nanog, 5'-AGG GTC TGC TAC TGA GAT GCT CTG -3' (sense) and 5'-CAA CCA CTG GTT TTT CTG CCA CCG -3' (antisense).
Selection and characterization of transfected cells
The transfected cells were cultured in the presence of 250 μg/ml G418 (Sigma-Aldrich) and G418 resistant cells were selected for 2-3 weeks. Cells were maintained on 0.1% gelatin-coated dish in ES culture medium supplemented with LIF. After culture for 3 weeks, GFP expression was determined by measuring fluorescence using FACScan (BD Biosciences). Expression of stem cell markers such as Oct-3/4, Sox-2, and Klf-4 was assessed by flow cytometry using FACScan.
Statistical analysis
Results are expressed as mean ± standard deviation.
Statistical significance between two samples was evaluated using the Student's t test. A p-value of <0.05 was taken as statistically significant. ( Fig. 1A) or FuGENE ® HD (Fig. 1B) . However, there was some difference in the efficacy of the transfection. (Huangfu et al., 2008a; Huangfu et al., 2008b) . TSA treatment after somatic nuclear transfer in mice dramatically improved the efficacy of current cloning technique (Kishigami et al., 2006) . 
RESULTS AND DISCUSSION
Transfected mouse ES cells maintain stem cell marker expression
Previous studies have shown that HDAC inhibitors, including TSA, induced the early differentiation and altered characterization of ES cell (Karantzali et al., 2008; Park et al., 2011) . It was also reported that mSin3A-HDAC complex is involved in the maintenance of ES cell pluripotency (Baltus et al., 2009) . Therefore, to evaluate whether these HDAC inhibitors change the stem cell properties during the transfection procedure in this study, we treated NaB 1 mM, VPA 1 mM, and TSA 25 nM for 24 hr after transfection with Lipofectamine TM 2000 and examined expression of the stem cell markers.
We first confirmed similar expression of stem cell markers Oct4 and Nanog mRNAs in the transfected ES cells (Fig. 3A) . Next, we analyzed the expression of stem cell markers such as Oct4, Nanog, Sox-2, and KLF4
after transfection procedure at the protein level. Expression of stem cell markers in the transfected cells was similar with that in the untreated control mouse ES cells as determined by FACS analysis (Fig. 3B) . These results of stem cell markers (Kim et al., 2012; Ware et al., 2009 
